The company shifted strategy around eight years ago to meet the needs of large cloud providers, wrote UBS lead analyst David ...
Q3 2025 Management View Richard Paulson, President and CEO, highlighted a "very productive quarter for Karyopharm, one defined by meaningful clinical progress and strengthened financial flexibility ...